Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Johnson and Johnson
Teva
McKinsey
Novartis
Deloitte
Julphar
US Department of Justice
Chubb

Generated: February 25, 2018

DrugPatentWatch Database Preview

AREDIA Drug Profile

« Back to Dashboard

Which patents cover Aredia, and when can generic versions of Aredia launch?

Aredia is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in AREDIA is pamidronate disodium. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.

US Patents and Regulatory Information for AREDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for AREDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
UBS
Baxter
Covington
Cipla
Harvard Business School
Moodys
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot